0001209191-20-050292.txt : 20200914 0001209191-20-050292.hdr.sgml : 20200914 20200914163936 ACCESSION NUMBER: 0001209191-20-050292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200914 DATE AS OF CHANGE: 20200914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEPORE PATRICK G CENTRAL INDEX KEY: 0001055404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 201173594 MAIL ADDRESS: STREET 1: 17-17 ROUTE 208 N CITY: FAIRLAWN STATE: NJ ZIP: 07410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VYNE Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 U.S. HIGHWAY 22, SUITE 204 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 800-775-7936 MAIL ADDRESS: STREET 1: 520 U.S. HIGHWAY 22, SUITE 204 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-10 0 0001566044 VYNE Therapeutics Inc. VYNE 0001055404 LEPORE PATRICK G 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 1 0 0 0 Stock Options 1.46 2020-09-10 4 A 0 45000 0.00 A 2030-09-10 Common Stock 45000 45000 D The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. /s/ Mutya Harsch, attorney-in-fact for Patrick LePore 2020-09-14